RetromanIE
23-01-2012, 09:52
<img alt="" height="1" width="1" />
Israel's 2012 drug basket backs rarer conditions (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVtxOuDErwYrq-N4hIcJUR4V5rkQ&url=http://www.pharmatimes.com/Article/12-01-23/Israel_s_2012_drug_basket_backs_rarer_conditions.a spx)
Pharma Times
Novartis' Afinitor (everolimus), which will now be provided free or at very low cost for the treatment of subependymal giant cell astrocytoma (SEGA) brain tumours, previously cost its six Israeli patients NIS141,000 each per year.
[/URL]
[url=http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVtxOuDErwYrq-N4hIcJUR4V5rkQ&url=http://www.pharmatimes.com/Article/12-01-23/Israel_s_2012_drug_basket_backs_rarer_conditions.a spx]More... (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=dyKJtYqrGw43MCM)
Israel's 2012 drug basket backs rarer conditions (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVtxOuDErwYrq-N4hIcJUR4V5rkQ&url=http://www.pharmatimes.com/Article/12-01-23/Israel_s_2012_drug_basket_backs_rarer_conditions.a spx)
Pharma Times
Novartis' Afinitor (everolimus), which will now be provided free or at very low cost for the treatment of subependymal giant cell astrocytoma (SEGA) brain tumours, previously cost its six Israeli patients NIS141,000 each per year.
[/URL]
[url=http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVtxOuDErwYrq-N4hIcJUR4V5rkQ&url=http://www.pharmatimes.com/Article/12-01-23/Israel_s_2012_drug_basket_backs_rarer_conditions.a spx]More... (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=dyKJtYqrGw43MCM)